Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extracellular degradation of a polyurethane oligomer involving outer membrane vesicles and further insights on the degradation of 2,4-diaminotoluene in Pseudomonas capeferrum TDA1.
Puiggené Ò, Espinosa MJC, Schlosser D, Thies S, Jehmlich N, Kappelmeyer U, Schreiber S, Wibberg D, Kalinowski J, Harms H, Heipieper HJ, Eberlein C. Puiggené Ò, et al. Among authors: schreiber s. Sci Rep. 2022 Feb 17;12(1):2666. doi: 10.1038/s41598-022-06558-0. Sci Rep. 2022. PMID: 35177693 Free PMC article.
An optimized method for RNA extraction from the polyurethane oligomer degrading strain Pseudomonas capeferrum TDA1 growing on aromatic substrates such as phenol and 2,4-diaminotoluene.
Cárdenas Espinosa MJ, Schmidgall T, Wagner G, Kappelmeyer U, Schreiber S, Heipieper HJ, Eberlein C. Cárdenas Espinosa MJ, et al. Among authors: schreiber s. PLoS One. 2021 Nov 15;16(11):e0260002. doi: 10.1371/journal.pone.0260002. eCollection 2021. PLoS One. 2021. PMID: 34780548 Free PMC article.
A first glimpse at the genome of the Baikalian amphipod Eulimnogammarus verrucosus.
Rivarola-Duarte L, Otto C, Jühling F, Schreiber S, Bedulina D, Jakob L, Gurkov A, Axenov-Gribanov D, Sahyoun AH, Lucassen M, Hackermüller J, Hoffmann S, Sartoris F, Pörtner HO, Timofeyev M, Luckenbach T, Stadler PF. Rivarola-Duarte L, et al. Among authors: schreiber s. J Exp Zool B Mol Dev Evol. 2014 May;322(3):177-89. doi: 10.1002/jez.b.22560. Epub 2014 Feb 12. J Exp Zool B Mol Dev Evol. 2014. PMID: 24677529 Free article.
Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.
Reiche K, Kasack K, Schreiber S, Lüders T, Due EU, Naume B, Riis M, Kristensen VN, Horn F, Børresen-Dale AL, Hackermüller J, Baumbusch LO. Reiche K, et al. Among authors: schreiber s. PLoS One. 2014 Sep 29;9(9):e106076. doi: 10.1371/journal.pone.0106076. eCollection 2014. PLoS One. 2014. PMID: 25264628 Free PMC article.
Evaluating the performance of multi-omics integration: a thyroid toxicity case study.
Canzler S, Schubert K, Rolle-Kampczyk UE, Wang Z, Schreiber S, Seitz H, Mockly S, Kamp H, Haake V, Huisinga M, Bergen MV, Buesen R, Hackermüller J. Canzler S, et al. Among authors: schreiber s. Arch Toxicol. 2025 Jan;99(1):309-332. doi: 10.1007/s00204-024-03876-2. Epub 2024 Oct 23. Arch Toxicol. 2025. PMID: 39441382 Free PMC article.
Risankizumab Efficacy and Safety Based on Prior Inadequate Response or Intolerance to Advanced Therapy: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies.
Panaccione R, Louis E, Colombel JF, D'Haens G, Peyrin-Biroulet L, Dubinsky M, Takeuchi K, Rubin DT, Kalabic J, Chien KB, Chen S, Cheng L, Zhang Y, Duan WR, Vladea R, Hecht PM, Morisset P, Schreiber S, Ferrante M. Panaccione R, et al. Among authors: schreiber s. J Crohns Colitis. 2025 Jan 13:jjaf005. doi: 10.1093/ecco-jcc/jjaf005. Online ahead of print. J Crohns Colitis. 2025. PMID: 39804294
Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn's Disease.
Feagan BG, Colombel JF, Panaccione R, Schreiber S, Ferrante M, Kamikozuru K, Ma C, Lee WJ, Griffith J, Joshi N, Kligys K, Kalabic J, Xuan S, Dubinsky M. Feagan BG, et al. Among authors: schreiber s. Gastro Hep Adv. 2024 Sep 5;4(1):100544. doi: 10.1016/j.gastha.2024.08.022. eCollection 2025. Gastro Hep Adv. 2024. PMID: 39802486 Free PMC article.
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial.
Sands BE, Panaccione R, D'Haens G, Schreiber S, Jairath V, DuVall A, Kierkus J, Walczak M, Naik S, Gilder K, Lindstrom B, Ogilvie K, Sandborn WJ, Vermeire S, Rubin DT, Peyrin-Biroulet L, Danese S. Sands BE, et al. Among authors: schreiber s. Lancet Gastroenterol Hepatol. 2025 Jan 7:S2468-1253(24)00386-8. doi: 10.1016/S2468-1253(24)00386-8. Online ahead of print. Lancet Gastroenterol Hepatol. 2025. PMID: 39793589
2,833 results